Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10455056.
- Also identified by PMC identifier 2720027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The epoxyeicosatrienoic acids (EETs) are products of cytochrome P450 epoxygenases that have vasodilatory properties similar to that of endothelium-derived hyperpolarizing factor. The cytochrome P450 isoform CYP2J2 was cloned and identified as a potential source of EETs in human endothelial cells. Physiological concentrations of EETs or overexpression of CYP2J2 decreased cytokine-induced endothelial cell adhesion molecule expression, and EETs prevented leukocyte adhesion to the vascular wall by a mechanism involving inhibition of transcription factor NF-kappaB and IkappaB kinase. The inhibitory effects of EETs were independent of their membrane-hyperpolarizing effects, suggesting that these molecules play an important nonvasodilatory role in vascular inflammation.
Medical subject headings
- 8,11,14-Eicosatrienoic Acid
- Anti-Inflammatory Agents, Non-Steroidal
- Cytochrome P-450 Enzyme System
- Endothelium, Vascular
- I-kappa B Proteins
- Oxygenases